Immune-related adverse events (irAE) in GU cancer patients receiving immune checkpoint inhibitors.

Zang, P; Drakaki, A; Faiena, I; Chan, B; Tsao-Wei, D; Groshen, SG; Quinn, DI; Dorff, TB

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (6):